Kestra Medical Technologies, Ltd. Variable Lease, Cost
Kestra Medical Technologies, Ltd. (KMTS) reported Variable Lease, Cost of $158.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. variable lease, cost for the quarter ending 2026-07-31 was $158.00K, a 4.24% decline year-over-year.
- Kestra Medical Technologies, Ltd. variable lease, cost for the quarter ending 2026-04-30 was $176.00K, a 0.57% increase year-over-year.
- Kestra Medical Technologies, Ltd. variable lease, cost for the quarter ending 2026-01-31 was $165.00K, a 6.45% increase year-over-year.
- Kestra Medical Technologies, Ltd. variable lease, cost for the quarter ending 2025-10-31 was $173.00K, a 13.07% increase year-over-year.
- Kestra Medical Technologies, Ltd. variable lease, cost for fiscal 2026 was $680.00K, a 6.92% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. variable lease, cost for fiscal 2025 was $636.00K, a 5.65% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. variable lease, cost for fiscal 2024 was $602.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-07-31 | $158.00K 10-Q · filed 2026-09-14 | $334.00K derived: sum of 2 quarters · filed 2026-09-14 | $499.00K derived: sum of 3 quarters · filed 2026-09-14 | $672.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $341.00K derived: sum of 2 quarters · filed 2026-07-14 | $514.00K derived: sum of 3 quarters · filed 2026-07-14 | $680.00K 10-K · filed 2026-07-14 |
| 2026-01-31 | $165.00K 10-Q · filed 2026-03-17 | $338.00K derived: sum of 2 quarters · filed 2026-03-17 | $504.00K 10-Q · filed 2026-03-17 | $678.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $173.00K 10-Q · filed 2025-12-11 | $339.00K 10-Q · filed 2025-12-11 | $513.00K derived: sum of 3 quarters · filed 2026-09-14 | $668.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $165.00K 10-Q · filed 2026-09-14 | $340.00K derived: sum of 2 quarters · filed 2026-09-14 | $495.00K derived: sum of 3 quarters · filed 2026-09-14 | $648.00K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $330.00K derived: sum of 2 quarters · filed 2026-07-14 | $483.00K derived: sum of 3 quarters · filed 2026-07-14 | $636.00K 10-K · filed 2026-07-14 |
| 2025-01-31 | $155.00K 10-Q · filed 2026-03-17 | $308.00K derived: sum of 2 quarters · filed 2026-03-17 | $461.00K 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $153.00K 10-Q · filed 2025-12-11 | $306.00K 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $153.00K 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $602.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |